Marin BM, Porath KA, Jain S, Kim M, et al. Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma. Neuro Oncol 2021 May 29. pii: 6288409. doi: 10.1093.
PMID: 34050676